Trial intelligence / Profile preview

Probiotics and PENS T6 for Weight Loss in Obese Patients

NCT03872245Phase 3Unknown

Sponsor
Hospital General Universitario de Elche
Start
Mar 2019
Primary completion
May 2019
01

Overview

Phase 3, randomised, open-label trial in obesity (2 arms), sponsored by Hospital General Universitario de Elche. Primary endpoint: Weight loss at 10 weeks. Status: unknown.

02

Conditions

obesity

Beyond the preview

Go deeper on NCT03872245.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03872245.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call